Delayed presentation of pembrolizumab-induced SJS-TEN overlap syndrome

Drew A. Wells, Gabriela Acton, Zachery Halford

Open source

DOI: 10.1177/10781552251409390
Published: 2025-12-19
Container: Journal of Oncology Pharmacy Practice
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/10781552251409390,
  title = {Delayed presentation of pembrolizumab-induced SJS-TEN overlap syndrome},
  author = {Drew A. Wells and Gabriela Acton and Zachery Halford},
  year = {2025},
  journal = {Journal of Oncology Pharmacy Practice},
  doi = {10.1177/10781552251409390},
  url = {https://doi.org/10.1177/10781552251409390}
}

RIS

TY  - JOUR
TI  - Delayed presentation of pembrolizumab-induced SJS-TEN overlap syndrome
AU  - Drew A. Wells
AU  - Gabriela Acton
AU  - Zachery Halford
PY  - 2025
JO  - Journal of Oncology Pharmacy Practice
DO  - 10.1177/10781552251409390
UR  - https://doi.org/10.1177/10781552251409390
ER  -

APA

Wells, D. A., Acton, G., & Halford, Z. (2025). Delayed presentation of pembrolizumab-induced SJS-TEN overlap syndrome. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552251409390

Source records

crossref · retrieved 2026-09-26T23:36:27.231Z